Venture Portfolio - Cell-Easy


Key Figures

  • 2015
    Creation Date
  • 14
    Number of Employees
  • 2020
    Investment Date
  • OMX
    Fund Name 

Company Presentation

Cell-Easy is a stem cell Contract Development and Manufacturing Organization (CDMO) that provides quick and easy access to ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects.

Their production process has been optimized under cGMP conditions and inspected by the French National Agency of Medicine and Health Products Safety (ANSM), in order to be scalable and guarantee optimal product safety, quality and efficacy for patients.


4 bis Avenue Hubert Curien - Bâtiment Incere - 31100 Toulouse - FRANCE

Key Contacts